☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
CNS diseases
PeptiDream and Takeda Expand its Research and License Agreement to Develop Peptide Drug Conjugates Targeting CNS Diseases
July 28, 2021
Roche Signs a License Agreement with Dyno to Develop AVV Gene Therapy for ~$1.8B
October 15, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
